New advances in breast cancer treatment

New progress in breast cancer treatment 1. Multidisciplinary integrated treatment modelThe treatment of breast cancer has entered the age of multidisciplinary and integrated treatment. Multidisciplinary combination therapy is the combination of surgical, therapeutic, chemotherapy, endocrinological and target-oriented treatments to improve the effectiveness of treatment. According to a study by Ho Ginme et al., the Gosartor stand-by shows a good cost-effectiveness ratio [9] in the treatment of HR+/HER2-late transferal breast cancer compared to single-drug chemotherapy. This model of multidisciplinary cooperation not only improves the effectiveness of treatment but also reduces unnecessary treatment costs.2. Target breakthroughs for treatmentTarget-oriented treatment is one of the major breakthroughs in breast cancer treatment. It reduces damage to normal cells by identifying and attacking cancer cell-specific targets, thus reducing side effects. Ms. Yu, among others, studied the efficacy and safety of the Apatini coalition against triple-negative breast cancer, showing the prospect of targeted treatment for this type of breast cancer [13]. In addition, Liu Wee-han et al. studied the mechanism of the role of CircZFAND6 in triple-vaginal breast cancer and provided new research directions for target treatment [20].3. Application of Chinese medicine in breast cancer treatmentChinese medicine also plays an important role in supporting breast cancer treatment. Lee Ronan et al. explored the effects of Chinese medicine on the pulmonary ecology before tumour transfer on the basis of the “first-to-be-safe” theory, indicating its potential role in breast cancer transfer [8]. Shi Jiacon and others have explored the treatment of breast cancer bone transfer on the basis of the “minor luminum” theory, suggesting that Chinese medicine, combined with modern medicine, can provide new ideas and approaches to breast cancer treatment [18].The treatment of breast cancer has evolved from a single operation or chemotherapy to today ‘ s multidisciplinary integrated and individualized treatment. The targeting of treatment and the application of Chinese medicine not only improves the effectiveness of treatment but also provides patients with more options. Breast cancer treatment will become more accurate and effective through ongoing research and clinical trials.References[1] Wang Joan, Seo Yanhua, Huang Ji-hwa, etc. Clinical case analysis of pulmonary pneumocular skin and skin re-emergence [J/OL]. CT theoretical and applied research, 1-6 [2024-10-31].[2] The impact of the spread of the disease in low-oxygen conditions on the growth of breast cancer cells and the associated aerobic deficiency factors;] J/OL. 2024-10-31].[3] Wang Fengxia, Symposia, Li Ying, etc. Expressions of non-special immersive breast cancer tissues ZEB2, SCUBE3 and their clinical significance studies [J/OL]. Advances in modern biomedicine, 1-4 [P] 2024-10-31].[4] Tang Chan, Zhao Haina, Pang Yulan, etc. One case of a combination of fat liver breast cancer followed by an unusual ultrasound of liver transfer [J/OL]. China intervention in image and therapeutics, 1-2 [2024-10-31].[5] Chen Chiu, Wang Smile, Zhao Peng, etc. 1 case of immersion of small leaf cancer in stomach transfer and literature review [J/OL]. Qingdao University Journal (Medical Edition), 1-3 [T] 2024-10-31].[6] Sna, Wang Xian, Kim Chee-mei, etc. One case of ultrasound of immersive breast-sifting cancer on the left side of an elderly male [J/OL]. China intervention in image and healing, 1-2 [2024-10-31].[7] Liu X-ray detection methods for medical mammography X-ray radiation sources and the effects of dosimetry on measurements [J]. Branding and standardization, 2024, (06): 258-261.[8] Li Joonan, Zhao Jung, Nii Bo Yi, etc. Exploring the effects of Chinese medicine on the pulmonary ecology of pre-tumour transfer [J/OL]. Liao Ning University Journal of Medicine, 1-12[1] 2024-10-31]. http://kns.cnki.net/kcms/detail/21.1543.R.20241029.12520.020.html.[9] Xinmei Ho, Xiao Li, Xiao Li, Liu Xiao Li, etc. Cost-effectiveness analysis for HR+/HER2-late transferal breast cancer treatment on a single anti-comparison pharmacological backline [J]. Chinese pharmacy, 2024, 35 (20): 2493-2498.[10] U.Y., Wang, RYU, etc. [J]. Nanchang University Journal of Science (medical edition), 2024, 64 (05): 1-9 DOI: 10.13764/j.cnki.ncdm.2024.05.001.[11] The value of new assisted treatments for breast cancer is predicted in the high snow plains, Liu Jia terms, Chen Jie-sik, etc. The blood plasma lncRNA SNHG12, miR-133b [J]. Test medicine and clinical, 2024, 21 (20): 2951-2957.[12] Chiang Lihua, Sun Yulan, Zhang De Goo. Analysis of the results of the survey of gynaecological diseases in Zhongming District, Shanghai, 2014-2022 [J]. Maternal and child health in China, 2024, 39 (21): 4287-4290. DOI: 10.19829/j.zgfybj.issn. 1001-4411-2024.21.039.[13] Yu Wei Hui, Wang Xiaoqiu, Zhao Li-Ping, etc. Apatini co-opts Reilly Joo to treat the efficacy and safety of triple-negative breast cancer [J]. China Maternal and Child Health Care, 2024, 39 (21): 4191-4194 DOI: 10.19829/j.zgfybj.issn. 1001-4411.2024.210.015.[14] Zhou Zhou Xiaoqing, Ji Wei Li. Impact of late-stage end-product receptor of glucose cellization on breast cancer cell proliferation, death, invasion and ability to migrate [J]. China Maternal and Child Health, 2024, 39 (21): 4295-4299 DOI: 10.19829/j.zgfybj.issn. 1001-44112024.21.041.41.[15] Chen, Wang Li, Liu Lina. Application of mammograms and dynamic magnetic resonance imaging in the mammary malignant pathologies and breast cancer in stages [J]. Practical medical video magazine, 2024, 25 (05): 331-334. DOI: 10.16106/j.cnki.cn14-1281/r.2024.05.002.[16] The impact of humanistic care based on the magnetic concept on the ability of patients to care for themselves, their behaviour and their level of hope for advanced breast cancer [J]. Kawabei Medical School Journal, 2024, 39 (10): 1432-1436.[17] The effect of the tactivist pellets on the atypical growth of mammograms, MVD and VEGF proteins [J]. Chinese Medicine Guide, 2024, 30 (10): 32-35+47. DOI: 10.13862j.cn43-1446/r.2024.100.006.[18] Xie Jiacon, Ei Feng Ting, Xu Xiao Ning, etc. … to explore the idea of breast cancer bone transfer treatment based on the theory of `Yoyang master bone’ [J]. Chinese Medicine Guide, 2024, 30 (10): 116-120. DOI:10.13862j.cn43-1446/r.2024.100.021.[19] Luyajun, Choi Jing, Lupin, etc. Multi-modular Care Application Observation for Breast Cancer Surgery [J]. Zhejiang Trauma Surgery, 2024, 29 (10): 1998-2000.[20] Liu Wee-han, Yip, Wang Jiang, etc. CircZFAND6 regulates the mechanism for the polarization of TAMs to M2 [J/OL]. Wahxia Medicine, 1-7[ 2024-10-31]. https://doi.org/10/19296/j.cnki.1008-2409.2024-05-001.